SAMe

non-nutrient/non-botanicalS-adenosyl-L-methionine

What is it

SAMe (S-adenosyl-L-methionine) is a naturally occurring compound present in every cell of the body. It is the body's principal methyl donor, participating in over 100 methyl-transfer reactions essential for neurotransmitter synthesis, DNA regulation, joint health, and liver function.

How it works

SAMe is synthesized inside cells from methionine and ATP by the enzyme methionine adenosyltransferase. Its core function is donating a methyl group (-CH3) to a wide range of acceptors: DNA (controlling gene expression and silencing), neurotransmitters (synthesizing serotonin, dopamine, norepinephrine), phospholipids (membrane structure), creatine, melatonin, hormones, and detoxification intermediates. After donating its methyl group, SAMe becomes S-adenosylhomocysteine and then homocysteine. Homocysteine can return to methionine (via remethylation requiring B12 and folate) or enter transsulfuration to produce cysteine, glutathione, and taurine (requiring B6). The integrity of this cycle requires adequate B-vitamin status. Supplemental SAMe is intended to boost methylation capacity, supporting neurotransmitter synthesis (relevant to mood), cartilage matrix methylation (relevant to osteoarthritis), and liver detoxification (relevant to certain liver diseases).

Evidence for 5 uses

AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.

Depression

Grade B

Good evidence

Multiple trials and meta-analyses support SAMe (800-1,600 mg/day) for depression, with efficacy comparable to tricyclics. May augment partial SSRI response. Onset 2-4 weeks.

Osteoarthritis

Grade B

Good evidence

SAMe (600-1,200 mg/day) provides pain and function improvements comparable to NSAIDs, with better GI tolerance. Onset is slower (4-8 weeks).

Cholestatic liver disease

Grade B

Good evidence

SAMe is used in some countries for intrahepatic cholestasis of pregnancy and alcoholic liver disease, with evidence of liver function improvement.

Fibromyalgia

Grade C

Moderate evidence

Small studies suggest possible modest pain and fatigue improvements. Evidence is mixed.

Cognitive support / brain fog

Grade D

Mixed evidence

Theoretically supports neurotransmitter synthesis. Direct cognitive evidence in healthy adults is limited.

2 commercial forms

SAMe tosylate disulfate (enteric coated)

The most common stable salt form; requires enteric coating to survive stomach acid.

Standard supplement form. Always confirm enteric coating to ensure activity.

SAMe butanedisulfonate (enteric coated)

Alternative stable salt with equivalent clinical efficacy.

Used in some European clinical products.

Dosage

Typical doses are 200-1,600 mg/day, starting at 200-400 mg and titrating up. For depression, 800-1,600 mg/day; for osteoarthritis, 600-1,200 mg/day. Use enteric-coated tablets for absorption. No formal UL.

When and how to take it

Take on an empty stomach (15-30 minutes before meals) for best absorption. Morning and midday dosing helps avoid sleep disruption from later doses. Enteric coating is essential. Pair with a B-complex providing B6, B12, and folate to support the methylation cycle.

Safety

SAMe is generally well-tolerated. Side effects include nausea, GI upset, headache, anxiety, insomnia, and (rarely) mania in bipolar individuals. May cause restlessness, especially with later-day dosing. Long-term use appears safe in European clinical experience. Pair with B vitamins (B12, folate, B6) to support healthy homocysteine metabolism.

Who should be cautious

Avoid in bipolar disorder unless under specialist care (risk of mania). Caution with antidepressants. Avoid in pregnancy and lactation due to insufficient safety data. Caution in Parkinson's disease on levodopa. Discuss with oncologist before use in cancer due to methylation effects.

Interactions

May potentiate serotonergic medications (SSRIs, MAOIs, tramadol) with risk of serotonin syndrome. May reduce levodopa effectiveness through methylation. May interact with dextromethorphan, meperidine, and other serotonin-affecting drugs. Adequate B-vitamin status prevents homocysteine accumulation.

Frequently asked questions

Is SAMe the same as SAM-e?⌄

Yes. The compound is S-adenosyl-L-methionine, written variously as SAM-e, SAMe, or AdoMet. They all refer to the same molecule.

How does SAMe compare to antidepressants?⌄

Trials show efficacy comparable to tricyclics for depression. It works through different mechanisms (methylation of neurotransmitter pathways) and is sometimes used to augment SSRI response.

Can SAMe help my joints?⌄

Yes, with reasonable evidence. SAMe (600-1,200 mg/day) provides similar pain relief to NSAIDs for osteoarthritis but with fewer GI side effects. Onset is slower (4-8 weeks).

Why must I take it on an empty stomach?⌄

Food slows absorption. SAMe is unstable in stomach acid; the enteric coating delays release until the intestine, where it absorbs better without food competition.

Is SAMe safe long-term?⌄

European clinical experience supports good long-term tolerability. Take with B-vitamins to keep homocysteine in check. Discuss with a clinician if used beyond a few months, especially if taking other medications.

References

  • SAMe - Wikidata — Wikidata link

Track SAMe with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.

Coming to App Store

Disclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you're pregnant, breastfeeding, on medications, or managing a chronic condition.